CD8A and breast carcinoma: To investigate the clinical relevance of our preclinical findings, we analyzed primary breast cancer tissues from a cohort of 54 patients, who had a metastatic relapse after primary tumor resection (Supplementary Table 1) for the presence of CD8, CD39, PD-1, and epithelial cells using 5-plex immunofluorescence (Fig. 6a).